Old Web
English
Sign In
Acemap
>
Paper
>
Safety and Tolerability of a 90-minute Infusion of Originator and Biosimilar Rituximab in Rituximab- Naïve Patients
Safety and Tolerability of a 90-minute Infusion of Originator and Biosimilar Rituximab in Rituximab- Naïve Patients
2021
Young-Hoon Park
Yeung-Chul Mun
Sewon Lee
Dae-Young Kim
Keywords:
Biosimilar
therapy naive
Tolerability
Rituximab
Oncology
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]